InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
The main objective of company is to develop a universal parental control platform that leveraged to the best of networking and application technology and one that worked at home, outside, within carrier networks, public hotspots and schools.
View the full Corporate Spotlight
How does Family Zone work?
Latest Threads
See All Discussions